Regeneron Pharmaceuticals (NASDAQ:REGN) has observed the following analyst ratings within the last quarter:
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 7 | 9 | 9 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 3 | 7 | 3 | 0 | 0 |
3M Ago | 3 | 2 | 5 | 0 | 0 |
In the last 3 months, 25 analysts have offered 12-month price targets for Regeneron Pharmaceuticals. The company has an average price target of $901.36 with a high of $1050.00 and a low of $720.00.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased